• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT ABSORB BIORESORBABLE VASCULAR SCAFFOLD SYSTEM; BIORESORBABLE DRUG ELUTING SCAFFOLD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT ABSORB BIORESORBABLE VASCULAR SCAFFOLD SYSTEM; BIORESORBABLE DRUG ELUTING SCAFFOLD Back to Search Results
Device Problem Device Operates Differently Than Expected (2913)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 12/04/2016
Event Type  Injury  
Manufacturer Narrative
(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.Date of event has been estimated.Implant date has been estimated.The absorb device is currently not commercially available in the u.S; however, it is similar to a device sold in the us.The scaffold remains in the patient.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Event Description
It was reported that the procedure was to treat a lesion located in the proximal and distal left anterior descending (lad) artery.Two absorb scaffolds were implanted approximately 3.5 years ago.The patient returned to the cath lab due to symptomatic chest pain, not sure whether this was a stemi or elective admission.The angiogram diagnostic showed no cause for concern in any of the arteries, but it was decided to perform coronary optical frequency domain imaging of the two scaffolds.In a few frames of the images `struts' still appeared present on the surface of the vessel wall of the proximal segment of the proximal scaffold.The patient was started on dual anti-platelet therapy again, due to the absence of healing, and risk of a thrombotic response to the struts location.The patient has suffered no major complication and the chest pain was not related to the appearance of the absorb scaffold.No additional information was provided.
 
Manufacturer Narrative
(b)(4).The udi is unknown because the part number and lot number were not provided.The device was not returned for evaluation.A review of the lot history record and complaint history of the reported device could not be conducted because the part and lot numbers were not provided.Based on the information reviewed, there is no indication of a product quality issue with respect to manufacture, design or labeling.One cine image was received and reviewed by an abbott vascular clinical specialist.The reviewer noted that it is possible that the original deployment was slightly undersized and left a few struts malapposed contributing to the slow resorption.Also, there appears to be a few remaining struts which are covered with a very shallow tissue layer.These may have originally also been malapposed and healed over much later.The investigation was unable to determine a conclusive cause for the reported slow resorption.Based on the information reviewed, there is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ABSORB BIORESORBABLE VASCULAR SCAFFOLD SYSTEM
Type of Device
BIORESORBABLE DRUG ELUTING SCAFFOLD
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, TEMECULA, CA USA REG# 2024168
abbott vascular
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
connie speck
abbott vascular
26531 ynez road
temecula, CA 92591-4628
9519143996
MDR Report Key6191471
MDR Text Key62909541
Report Number2024168-2016-09063
Device Sequence Number1
Product Code PNY
Combination Product (y/n)N
Reporter Country CodeUK
PMA/PMN Number
P150023
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Health Professional
Remedial Action Other
Type of Report Initial,Followup
Report Date 02/08/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/20/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/02/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
OTHER: ABSORB SCAFFOLD
Patient Outcome(s) Required Intervention;
-
-